Product Information
LY-456236 is a piperazine compound that inhibits the activity of β-catenin, which is a protein that plays a key role in cell signaling. Inhibiting β-catenin may lead to an improvement in psychotic disorders. LY-456236 has shown to inhibit glutamate release and activity of glutamate receptor subtype NMDARs, which are involved in neuronal function. This drug also inhibits locomotor activity and induces brain infarction in rats, suggesting that it could have potential as a treatment for Parkinson's disease.
Chemical properties
Technical inquiry about: 3D-NNA73646 LY-456236
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
